Ask AI

CCO Official Conference Coverage of IAS 2025: The Latest Updates in HIV *

This program outlines important data and highlights from the 13th International AIDS Society (IAS) Conference on HIV Science.

Share

Program Content

Activities

Themes From IAS 2025
Themes From IAS 2025: Emerging Evidence, Innovations, and Global Challenges
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: July 11, 2025

HIV Response
Why the HIV Response Must Evolve for People Already Living With HIV
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2025

IAS 2025 Weight Management
Rethinking Weight Management in People Living With HIV: Perspectives From Australia on IAS 2025
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2025

IAS 2025 Retrospective
Hope in the Face of Hardship: IAS 2025
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 05, 2025

PrEP for Latin America
New Frontiers in PrEP and the Urgent Need for Latin America
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 06, 2025

HIV Progress and Challenges
IAS 2025: HIV Progress and Challenges in Canada and Globally
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 07, 2025

18 Capsule Summaries

Activities

ACTG A5391 DO IT
ACTG A5391/DO-IT Trial: Switching to DOR ± TDF vs Continuing INSTI + TAF/FTC in People With Obesity and HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Ulonivirine and Islatravir
Switch to Ulonivirine + Islatravir in Adults With Virologically Suppressed HIV-1: Phase IIb Trial
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 15, 2025

Real-world LA CAB + RPV With Viremia in OPERA
Switch to LA CAB + RPV in People With HIV and Detectable Viral Load in OPERA Cohort
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 16, 2025

TECAIN
TECAIN: Randomized Trial of Topical Trichloroacetic Acid vs Electrocautery for AIN in People With HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

SaDAPT
SaDAPT: Same-Day ART for People With HIV and Presumptive TB in Lesotho and Malawi
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

HBV Risk With LA ART
IMPALA Subanalysis: Risk of de novo HBV Infection in Nonimmune People With HIV Using LA CAB + RPV ART
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

VOLITION
VOLITION: Interim Analysis From Phase IIIb Trial of Optional Switch to LA CAB + RPV Following ART Initiation on DTG/3TC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

ODYSSEY Substudy
ODYSSEY: Predictors of First-line ART Failure in Children With HIV
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

Trio
Predictors of Significant Weight Gain in People With HIV on ART in the Trio Cohort Over 3-Year Period: Retrospective Analysis
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 30, 2025

BREATHER Plus
BREATHER Plus: Short-Cycle vs Continuous ART in Adolescents Living With HIV Receiving DTG + TDF/3TC in Sub-Saharan Africa
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 17, 2025

IMPALA
IMPALA: Long-acting Cabotegravir + Rilpivirine in Adults With Poorly Controlled HIV Infection in Sub-Saharan Africa
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2025

HRF-10071 Phase IIa
HRF-10071: Phase IIa Dose-Ranging, Monotherapy Trial of a Next-generation HIV-1 Maturation Inhibitor in People With HIV Infection
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2025

MK 8527
Phase IIa Trial of Once-Monthly MK-8527 as Oral PrEP in Adults at Low Risk of HIV-1 Exposure
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2025

Pregnancy Outcomes With CAB
Antiretroviral Pregnancy Registry Analysis of Pregnancy and Neonatal Outcomes Following Prenatal Cabotegravir Exposure 
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 18, 2025

PALM 007 Safety
PALM 007: Safety of Tecovirimat for the Treatment of Mpox in the Democratic Republic of Congo
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 21, 2025

PURPOSE 1 Substudy
PURPOSE 1 Substudy: Efficacy, Safety, and PK of Lenacapavir for PrEP in Pregnant and Lactating People
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2025

PURPOSE 1 and PURPOSE 2 Results in Adolescents and Young Adults
PURPOSE 1 and PURPOSE 2: Efficacy, Safety, and PK of Twice-Yearly Subcutaneous Lenacapavir for PrEP in Adolescents and Young Adults
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 22, 2025

LEN PrEP Patient Preferences
PURPOSE 2: PrEP Administration Preferences Among Cisgender Men and Gender Diverse Individuals
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 23, 2025

Activities

IAS Conference 2025
HIV Update: CCO Official Conference Coverage of IAS 2025
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 29, 2025

Activities

HIV Update IAS 2025
HIV Update Webinar 2 : CCO Official Conference Coverage of IAS 2025
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 31, 2025

HIV Update IAS 2025
HIV Update Webinar 1 : CCO Official Conference Coverage of IAS 2025
Video
Congratulations: You achieved a completion on 04/09/2022

Released: August 01, 2025

Faculty

cover img faculity

Claudia P. Cortes, MD

Associate Professor
University of Chile
Director of Center for HIV/AIDS Integral Research (CHAIR)
University of Chile School of Medicine
Santiago, Chile

cover img faculity

Eric S. Daar, MD

Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Beatriz Grinsztejn, MD, PhD

Director
STI/HIV Clinical Research Laboratory
Evandro Chagas National Institute of Infectious Diseases – FIOCRUZ
Rio de Janeiro, Brazil

cover img faculity

Daniel R. Kuritzkes, MD

Chief, Division of Infectious Diseases
Brigham and Women's Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

cover img faculity

Gail Matthews, MD, PhD, Prof

Professor Infectious Diseases
St Vincents Hospital and Kirby Institute, UNSW
Sydney, Australia

cover img faculity

Rosie Mngqibisa, MBChB, MPH

Clinical Director
Principal Investigator
Enhancing Care Foundation
Durban, South Africa

cover img faculity

Nomonde Ngema

Patient

cover img faculity

Kenneth Ngure, MPH, MSc, PhD

Associate Professor
School of Public Health JKUAT
Nairobi, Kenya

cover img faculity

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Honorary Consultant Physician Barts Health NHS Trust
Director, SHARE Collaborative
Queen Mary University of London
London, United Kingdom

cover img faculity

Jürgen K. Rockstroh, MD

Professor of Medicine
Head of Infectious Diseases
Department of Medicine I
University Hospital Bonn
Bonn, Germany

cover img faculity

Alexander Wong, MD, FRCPC

Associate Professor of Medicine
Division of Infectious Diseases
University of Saskatchewan
Regina, Saskatchewan, Canada

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC  in partnership with the International AIDS Society  

Supporters

Supported by educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Partners

IAS

ProCE Banner

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.